Prasad U - Search Results

1

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.

Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Pathmanathan R, et al. Among authors: prasad u. N Engl J Med. 1995 Sep 14;333(11):693-8. doi: 10.1056/NEJM199509143331103. N Engl J Med. 1995. PMID: 7637746

2

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, Rickinson AB. Sam CK, et al. Among authors: prasad u. Int J Cancer. 1993 Apr 1;53(6):957-62. doi: 10.1002/ijc.2910530616. Int J Cancer. 1993. PMID: 8386141

3

The culture of epithelial cells from nasopharyngeal carcinoma biopsies.

Kook SC, Prasad U. Kook SC, et al. Among authors: prasad u. In Vitro Cell Dev Biol. 1986 Nov;22(11):627-31. doi: 10.1007/BF02623475. In Vitro Cell Dev Biol. 1986. PMID: 3782005

4

Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.

Foong YT, Cheng HM, Sam CK, Dillner J, Hinderer W, Prasad U. Foong YT, et al. Among authors: prasad u. Int J Cancer. 1990 Jun 15;45(6):1061-4. doi: 10.1002/ijc.2910450614. Int J Cancer. 1990. PMID: 1693600

5

Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization.

Yao QY, Rowe M, Morgan AJ, Sam CK, Prasad U, Dang H, Zeng Y, Rickinson AB. Yao QY, et al. Among authors: prasad u. Int J Cancer. 1991 Apr 22;48(1):45-50. doi: 10.1002/ijc.2910480109. Int J Cancer. 1991. PMID: 1850382

6

Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.

Sam CK, Prasad U, Pathmanathan R. Sam CK, et al. Among authors: prasad u. Eur J Surg Oncol. 1989 Aug;15(4):357-60. Eur J Surg Oncol. 1989. PMID: 2547665

7

The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.

Xu J, Ahmad A, Blagdon M, D'Addario M, Jones JF, Dolcetti R, Vaccher E, Prasad U, Menezes J. Xu J, et al. Among authors: prasad u. Int J Cancer. 1998 Oct 23;79(5):481-6. doi: 10.1002/(sici)1097-0215(19981023)79:5<481::aid-ijc6>3.0.co;2-x. Int J Cancer. 1998. PMID: 9761116

8

Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.

Xu J, Menezes J, Prasad U, Ahmad A. Xu J, et al. Among authors: prasad u. Int J Cancer. 1999 Aug 20;84(4):396-9. doi: 10.1002/(sici)1097-0215(19990820)84:4<396::aid-ijc11>3.0.co;2-#. Int J Cancer. 1999. PMID: 10404092

9

Elevated secretory IgA antibodies to Epstein-Barr virus (EBV) and presence of EBV DNA and EBV receptors in patients with cervical carcinoma.

Se Thoe SY, Wong KK, Pathmanathan R, Sam CK, Cheng HM, Prasad U. Se Thoe SY, et al. Among authors: prasad u. Gynecol Oncol. 1993 Aug;50(2):168-72. doi: 10.1006/gyno.1993.1187. Gynecol Oncol. 1993. PMID: 8397152

10

A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.

Mathew A, Cheng HM, Sam CK, Joab I, Prasad U, Cochet C. Mathew A, et al. Among authors: prasad u. Cancer Immunol Immunother. 1994 Jan;38(1):68-70. doi: 10.1007/BF01517172. Cancer Immunol Immunother. 1994. PMID: 8299121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results